Santher Acquisition 100 percent Complete: Revenue Rises 11 percent in the First Quarter

The acquisition of Brazilian tissue producer Santher by Japanese groups Daio and Marubeni was completed on June 29, the companies confirmed. The operation was approved without restrictions by the Brazilian antitrust authority Cade. “Through Santher, Daio and Marubeni seek to expand their hygiene and personal care business to the entire South American market and furthermore to the African market in the future,” the companies said.

Daio reported it intends to make use of its strengths and stimulate the further growth of Santher by entering into the manufacturing and sales of adult disposable diapers, as well as extending its premium product lineup. Meanwhile, Marubeni stated it seeks to enhance Santher’s corporate value by integrating Marubeni’s existing functions, resources and networks as a general trading house, and through Santher’s business, “contribute to the realization of a hygienic environment and safe and comfortable lifestyles.”

With the acquisition, Hiroyuki Fujita, who currently holds the position of director responsible for Brazil, Corporate Planning Division, Corporate Unit in Daio, has been appointed as the chairman of the board of directors of Santher, and Yoshisato Esaka from Marubeni has been appointed as the vice president of Santher. The Brazilian executive José Rubens de La Rosa remains as CEO.

Santher also released its first quarter results of 2020, showing an 11.8-percent growth in revenues during the first quarter of 2020, totaling Real 420 million ($77 million). Sales surged by the end of March as a consequence of the COVID-19 pandemic, the company said in its results release.

“After a momentary increase in March and April, tissue consumption is back to normal,” Santher said. “The products sold by the company are of daily usage, which means they are less affected by the variations in the population’s purchasing power.”

Back to Tissue360 Newsletter